New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP

The metabolism of di(2-ethylhexyl)phthalate (DEHP) in humans was studied after three doses of 0.35 mg (4.7 μg/kg), 2.15 mg (28.7 μg/kg) and 48.5 mg (650 μg/kg) of D4-ring-labelled DEHP were administered orally to a male volunteer. Two new metabolites, mono(2-ethyl-5-carboxypentyl)phthalate (5cx-MEPP) and mono[2-(carboxymethyl)hexyl]phthalate (2cx-MMHP) were monitored for 44 h in urine and for 8 h in serum for the high-dose case, in addition to the three metabolites previously analysed: mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP), mono(2-ethyl-5-oxohexyl)phthalate (5oxo-MEHP) and mono(2-ethylhexyl)phthalate (MEHP). For the medium- and low-dose cases, 24 h urine samples were analysed. Up to 12 h after the dose, 5OH-MEHP was the major urinary metabolite, after 12 h it was 5cx-MEPP, and after 24 h it was 2cx-MMHP. The elimination half-lives of 5cx-MEHP and 2cx-MMHP were between 15 and 24 h. After 24 h 67.0% (range: 65.8–70.5%) of the DEHP dose was excreted in urine, comprising 5OH-MEHP (23.3%), 5cx-MEPP (18.5%), 5oxo-MEHP (15.0%), MEHP (5.9%) and 2cx-MMHP (4.2%). An additional 3.8% of the DEHP dose was excreted on the second day, comprising 2cx-MMHP (1.6%), 5cx-MEPP (1.2%), 5OH-MEHP (0.6%) and 5oxo-MEHP (0.4%). In total about 75% of the administered DEHP dose was excreted in urine after two days. Therefore, in contrast to previous studies, most of the orally administered DEHP is systemically absorbed and excreted in urine. No dose dependency in metabolism and excretion was observed. The secondary metabolites of DEHP are superior biomonitoring markers compared to any other parameters, such as MEHP in urine or blood. 5OH-MEHP and 5oxo-MEHP in urine reflect short-term and 5cx-MEHP and 2cx-MMHP long-term exposure. All secondary metabolites are unsusceptible to contamination. Furthermore, there are strong hints that the secondary oxidised DEHP metabolites—not DEHP or MEHP—are the ultimate developmental toxicants.

[1]  Holger M Koch,et al.  An estimation of the daily intake of di(2-ethylhexyl)phthalate (DEHP) and other phthalates in the general population. , 2003, International journal of hygiene and environmental health.

[2]  J. Fisher,et al.  Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome. , 2004, Reproduction.

[3]  Holger M. Koch,et al.  Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP , 2004, Archives of Toxicology.

[4]  Ibrahim Chahoud,et al.  Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono(2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets. , 2004, Toxicology and applied pharmacology.

[5]  R. Henderson,et al.  NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate. , 2002, Reproductive toxicology.

[6]  J. Angerer,et al.  Monophthalates with Oxidized C5-Carbon in the Ester Chain: A Simple Synthetic Access to Two Major Metabolites of Bis-(2-ethylhexyl)-phthalate , 2002 .

[7]  J. Angerer,et al.  Biological monitoring of the five major metabolites of di-(2-ethylhexyl)phthalate (DEHP) in human urine using column-switching liquid chromatography-tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  J. Angerer,et al.  Convenient and High-Yielding Preparations of Mono(5-carboxy-2-ethylpentyl) Phthalate and its Ring-Deuterated Isomer – The “Third” Major Metabolite of Bis(2-ethylhexyl) Phthalate , 2005, Monatshefte für Chemie - Chemical Monthly.

[9]  Holger M Koch,et al.  Internal exposure of the general population to DEHP and other phthalates--determination of secondary and primary phthalate monoester metabolites in urine. , 2003, Environmental research.

[10]  Response to the letter of R. M. David Int. J. Hyg. Environ. Health 207, 75 – 76 (2004) , 2004 .

[11]  J. Angerer,et al.  DEHP metabolites in urine of children and DEHP in house dust. , 2004, International journal of hygiene and environmental health.

[12]  Robert W. Moore,et al.  Abnormalities of sexual development in male rats with in utero and lactational exposure to the antiandrogenic plasticizer Di(2-ethylhexyl) phthalate. , 2001, Environmental health perspectives.

[13]  J. Angerer,et al.  (2-Ethyl-5-oxo-hexyl) Methylthiomethyl Phthalate as By-product of the Swern Oxidation: Improved Synthesis of Ring-deuterated Major Metabolites of Bis(2-ethylhexyl) Phthalate , 2003 .

[14]  A. Calafat,et al.  Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. , 2004, Environmental health perspectives.

[15]  P. Albro,et al.  Toxic potential of the plasticizer Di(2-ethylhexyl) phthalate in the context of its disposition and metabolism in primates and man. , 1982, Environmental health perspectives.

[16]  A. Calafat,et al.  Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. , 2003, Environmental health perspectives.

[17]  C. Schlatter,et al.  Excretion and metabolism of di(2-ethylhexyl)phthalate in man. , 1985, Xenobiotica; the fate of foreign compounds in biological systems.

[18]  J. Angerer,et al.  On-line clean-up by multidimensional liquid chromatography-electrospray ionization tandem mass spectrometry for high throughput quantification of primary and secondary phthalate metabolites in human urine. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[19]  Holger M Koch,et al.  Internal exposure of nursery-school children and their parents and teachers to di(2-ethylhexyl)phthalate (DEHP). , 2004, International journal of hygiene and environmental health.

[20]  D Stewart Irvine,et al.  How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health? , 2004, BMJ : British Medical Journal.

[21]  J. Teague,et al.  Reproductive effects of four phthalic acid esters in the mouse. , 1987, Toxicology and applied pharmacology.

[22]  H. Dirven,et al.  Determination of four metabolites of the plasticizer di (2-ethylhexyl) phthalate in human urine samples , 1993, International archives of occupational and environmental health.

[23]  A. Calafat,et al.  Detection of Phthalate Metabolites in Human Amniotic Fluid , 2004, Bulletin of environmental contamination and toxicology.

[24]  J. Brock,et al.  Quantitative detection of nine phthalate metabolites in human serum using reversed-phase high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. , 2003, Journal of analytical toxicology.

[25]  T. Lovekamp-Swan,et al.  Mechanisms of phthalate ester toxicity in the female reproductive system. , 2002, Environmental health perspectives.

[26]  U. Magnusson,et al.  Kinetics of orally administered di(2-ethylhexyl) phthalate and its metabolite, mono(2-ethylhexyl) phthalate, in male pigs , 2004, Archives of Toxicology.

[27]  R. T. Youker,et al.  Modulation of Rat Leydig Cell Steroidogenic Function by Di(2-Ethylhexyl)Phthalate1 , 2001, Biology of reproduction.

[28]  L. Gray,et al.  The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  P. Albro,et al.  Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP. , 1982, Environmental health perspectives.